GeneDx Holdings Corp.
WGS· Nasdaq
WGSGeneDx Holdings Corp.
Filed May 12, 2022 · 10-Q · 42 days after period end · 0001818331-22-000046
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Revenue | $53.94M | $64.20M | $46.66M |
| Net Income | -$76.90M | -$191.78M | -$26.99M |
| EPS Diluted | -$10.38 | -$348.82 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 12, 2022 · 42 d after period end
